title: Therapeutic vaccine for treatment of genital herpes enters phase 2.
authors: Eva M
authors: EM
authors: Riedmann
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects; D017322:Clinical Trials, Phase II as Topic; D006558:Herpes Genitalis / Q000628:therapy*; D022283:Herpesvirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D022283:Herpesvirus Vaccines; D014614:Vaccines, Synthetic